Upcoming JAX Event

This event has been postponed. If you are interested in updates and being notified when the date is announced please fill out the form below.

Interact with key opinion leaders in the field from both academia and industry along with JAX scientific experts, including:

• Gestur Vidarsson, Ph.D., Head of Immunoglobulin Research and Principal Investigator, Academic Medical Center, Amsterdam, The Netherlands
• Greg Christianson, Study Director In Vivo Pharmacology, The Jackson Laboratory, Maine, US
• Jan Terje Andersen, Ph.D., Research Group Leader, Oslo University Hospital and University of Oslo, Norway
• Michael Otteneder Ph.D., Pharmaceutical Sciences pRED, Roche Innovation Center, Basel, Switzerland
• Derry Roopenian, Ph.D., Professor Emeritus, The Jackson Laboratory, Maine, US

We'll be discussing important topics such as:

• The role of FcRn in modulating the immune system function in both healthy and disease states
• Accurate measurement of antibody half-life to be cost-efficient and translationally relevant
• Optimizing the pharmacokinetics of FcRn-binding therapies
• Utilizing FcRn for autoimmune disease research

Fill out the form below to request a seat at this event